{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:59:13Z","timestamp":1792051153868,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is a chronic papulosquamous skin disease with an autoimmune pathogenic traits and strong genetic predisposition. In the past few decades, with the rapid development of molecular biology and cell biology, the inherent pathogenesis of psoriasis has been gradually elucidated, in which cytokine inflammatory loops, cell signaling pathways, and epigenetic factors such as miRNAs have been demonstrated to play important roles in regulating the development and progression of psoriasis. More importantly, understanding the pathogenesis of psoriasis has promoted the development of effective treatment for psoriasis. In this review, we systemically summarized the molecular mechanisms regulating the development and progression psoriasis, introduced various therapeutics used for clinical psoriasis therapy, and highlighted the recent advances in nanoparticles (NPs)-mediated drug delivery for psoriasis treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1089262","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:00:58Z","timestamp":1671710458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qian","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.94832","article-title":"Pathogenesis of psoriasis in the \"omic\" era. part i. epidemiology, clinical manifestation, immunological and neuroendocrine disturbances","volume":"37","author":"Samotij","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143394","article-title":"Th17 cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases","author":"Bunte","year":"2019","journal-title":"Int J Mol Sci 20"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01134-4","article-title":"The immunology of psoriasis and biologic immunotherapy","volume":"49","author":"Mehlis","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000275198","article-title":"High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice","volume":"220","author":"Saurat","year":"2010","journal-title":"Dermatology"},{"key":"B9","first-page":"77","article-title":"Conventional therapies for psoriasis","author":"Rebora","year":"2007","journal-title":"Reumatismo"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-4-1","article-title":"Bimekizumab: the new drug in the biologics armamentarium for psoriasis","author":"Freitas","year":"2021","journal-title":"Drugs Context 10"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094983","article-title":"Psoriasis: From pathogenesis to pharmacological and nano-Technological-Based therapeutics","author":"Petit","year":"2021","journal-title":"Int J Mol Sci 22"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.982088","article-title":"Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy","volume":"12","author":"Rahman","year":"2015","journal-title":"Expert Opin Drug Delivery"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.262","article-title":"Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity","volume":"132","author":"Kennedy-Crispin","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflammation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T Cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2018.04.016","article-title":"NFKB1 mediates Th1\/Th17 activation in the pathogenesis of psoriasis","volume":"331","author":"Zhou","year":"2018","journal-title":"Cell Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2018.72.410-413","article-title":"Serum concentrations of interferon gamma (IFN-\u03b3) in patients with psoriasis: Correlation with clinical type and severity of the disease","volume":"72","author":"Kurtovic","year":"2018","journal-title":"Med Arch"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.458","article-title":"A single intradermal injection of IFN-\u03b3 induces an inflammatory state in both non-lesional psoriatic and healthy skin","volume":"132","author":"Johnson-Huang","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.141","article-title":"Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model","volume":"17","author":"Jakobsen","year":"2009","journal-title":"Mol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24100","article-title":"Psoriasis associated with tumor necrosis factor inhibitors in children with inflammatory diseases","volume":"73","author":"Buckley","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09662.x","article-title":"Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation","volume":"162","author":"Renne","year":"2010","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B26","article-title":"Targeting the IL-1 family members in skin inflammation","volume":"11","author":"Jensen","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"964069","DOI":"10.1155\/2014\/964069","article-title":"IL-6 as a druggable target in psoriasis: focus on pustular variants","volume":"2014","author":"Saggini","year":"2014","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01865","article-title":"IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-Severe plaque psoriasis patients","volume":"10","author":"Shi","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.02.019","article-title":"IL-33 contributes to disease severity in psoriasis-like models of mouse","volume":"119","author":"Duan","year":"2019","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000688","article-title":"IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis","author":"Goldstein","year":"2020","journal-title":"Life Sci Alliance 3"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S257647","article-title":"IL-33\/13 axis and IL-4\/31 axis play distinct roles in inflammatory process and itch in psoriasis and atopic dermatitis","volume":"13","author":"Bodoor","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/702763","article-title":"Serum cytokines correlated with the disease severity of generalized pustular psoriasis","volume":"34","author":"Yamamoto","year":"2013","journal-title":"Dis Markers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1556\/AMicr.60.2013.2.7","article-title":"Expression patterns of Th1\/Th2 transcription factors in patients with guttate psoriasis","volume":"60","author":"Vanaki","year":"2013","journal-title":"Acta Microbiol Immunol Hung"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13267","article-title":"Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-\u03b1 treatment","volume":"26","author":"Balato","year":"2017","journal-title":"Exp Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031693","article-title":"Predominant role of mTOR signaling in skin diseases with therapeutic potential","author":"Karagianni","year":"2022","journal-title":"Int J Mol Sci 23"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13325","article-title":"Different epigenome regulation and transcriptome expression of CD4(+) and CD8(+) T cells from monozygotic twins discordant for psoriasis","volume":"61","author":"Li","year":"2020","journal-title":"Australas J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice","volume":"97","author":"B\u00fcrger","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12903","article-title":"JAK\/STAT pathway modulation: Does it work in dermatology","volume":"32","author":"G\u00fcnd\u00fcz","year":"2019","journal-title":"Dermatol Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu Rev Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: The promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1684\/ejd.2015.2663","article-title":"Topical therapy for psoriasis: a promising future","volume":"26","author":"Rafael","year":"2016","journal-title":"Focus JAK phosphodiesterase-4 inhibitors. Eur J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00569","article-title":"MAPK phosphatase-1 deficiency exacerbates the severity of imiquimod-induced psoriasiform skin disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"569751","DOI":"10.1155\/2013\/569751","article-title":"The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200471","article-title":"Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-\u03baB\/MAPK pathway","author":"Liu","year":"2020","journal-title":"Biosci Rep 40"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmz095","article-title":"FGF-7 facilitates the process of psoriasis by inducing TNF-\u03b1 expression in HaCaT cells","volume":"51","author":"Pu","year":"2019","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2133.2010.09790.x","article-title":"Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased hes-1 expression in bone marrow mononuclear cells from patients with psoriasis","volume":"163","author":"Zhang","year":"2010","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009258","article-title":"Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of notch signaling in the murine skin","volume":"5","author":"Dumortier","year":"2010","journal-title":"PLos One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16962","article-title":"Increased expression profile of NCSTN, notch and PI3K\/AKT3 in hidradenitis suppurativa","volume":"35","author":"Hessam","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.67","article-title":"Evidence for altered wnt signaling in psoriatic skin","volume":"130","author":"Gudjonsson","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13103","article-title":"FGF19 sustains the high proliferative ability of keratinocytes in psoriasis through the regulation of Wnt\/GSK-3\u03b2\/\u03b2-catenin signalling via FGFR4","volume":"46","author":"Yu","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168603","article-title":"Analysis of PPAR\u03b3 signaling activity in psoriasis","author":"Sobolev","year":"2021","journal-title":"Int J Mol Sci 22"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134217","article-title":"The CDK4\/6-EZH2 pathway is a potential therapeutic target for psoriasis","volume":"130","author":"M\u00fcller","year":"2020","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","first-page":"104496","DOI":"10.1016\/j.cellimm.2022.104496","article-title":"Par3 regulates the asymmetric division of basal stem cells in psoriasis via the Par3\/mInsc\/LGN signaling axis","volume":"373","author":"Yan","year":"2022","journal-title":"Cell Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097434","article-title":"MicroRNA-directed cleavage of HOXB8 mRNA","volume":"304","author":"Yekta","year":"2004","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933615","article-title":"Roles of miR-31 and endothelin-1 in psoriasis vulgaris: pathophysiological functions and potential biomarkers","volume":"66","author":"Borska","year":"2017","journal-title":"Physiol Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202695","article-title":"MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40","volume":"190","author":"Xu","year":"2013","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLos One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: a typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13861","article-title":"Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity","volume":"31","author":"Garc\u00eda-Rodr\u00edguez","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.05.005","article-title":"MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis","volume":"75","author":"L\u00f8vendorf","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0859-7","article-title":"miR-320b is down-regulated in psoriasis and modulates keratinocyte proliferation by targeting AKT3","volume":"41","author":"Wang","year":"2018","journal-title":"Inflammation"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15370","article-title":"miR-205-5p inhibits psoriasis-associated proliferation and angiogenesis: Wnt\/\u03b2-catenin and mitogen-activated protein kinase signaling pathway are involved","volume":"47","author":"Xue","year":"2020","journal-title":"J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci 20"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"B69","article-title":"Effectiveness of topical corticosteroid, topical calcineurin inhibitors and combination of them in the treatment of vitiligo","volume":"25","author":"Roy","year":"2016","journal-title":"Mymensingh Med J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21121719","article-title":"Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting","author":"Palmer","year":"2016","journal-title":"Molecules 21"},{"key":"B71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2014.09.021","article-title":"Targeted cutaneous delivery of ciclosporin a using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways","volume":"196","author":"Lapteva","year":"2014","journal-title":"J Control Release"},{"key":"B72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/08982104.2019.1593449","article-title":"Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis","volume":"30","author":"Walunj","year":"2020","journal-title":"J Liposome Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2015.1026605","article-title":"A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation","volume":"21","author":"Avasatthi","year":"2016","journal-title":"Pharm Dev Technol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jid.2019.09.018","article-title":"Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis","volume":"140","author":"\u00d6zcan","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr331","article-title":"Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome","volume":"20","author":"Joyce","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.11.013","article-title":"Towards topical microRNA-directed therapy for epidermal disorders","volume":"269","author":"Ross","year":"2018","journal-title":"J Control Release"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15149","article-title":"Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"47","author":"Feng","year":"2020","journal-title":"J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.13.202","article-title":"Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques","volume":"9","author":"Marepally","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"J Control Release"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00080","article-title":"RNA-Seq analysis of IL-1B and IL-36 responses in epidermal keratinocytes identifies a shared MyD88-dependent gene signature","volume":"9","author":"Swindell","year":"2018","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","author":"Wan","year":"2021","journal-title":"Sci Adv 7"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.08.018","article-title":"Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract","volume":"122","author":"David","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B85","doi-asserted-by":"publisher","first-page":"110709","DOI":"10.1016\/j.msec.2020.110709","article-title":"Modulatory effects of cornus sanguinea l. mediated green synthesized silver nanoparticles on oxidative stress, COX-2\/NOS2 and NFkB\/pNFkB expressions in experimental inflammation in wistar rats","volume":"110","author":"David","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.1c02899","article-title":"Alkyl-terminated gold nanoparticles as a self-therapeutic treatment for psoriasis","volume":"21","author":"Han","year":"2021","journal-title":"Nano Lett"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201201528","article-title":"Gold nanoparticles downregulate interleukin-1\u03b2-induced pro-inflammatory responses","volume":"9","author":"Sumbayev","year":"2013","journal-title":"Small"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13707","article-title":"Topical silver and gold nanoparticles complexed with cornus mas suppress inflammation in human psoriasis plaques by inhibiting NF-\u03baB activity","volume":"27","author":"Crisan","year":"2018","journal-title":"Exp Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2022.02.003","article-title":"Alantolactone-loaded chitosan\/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment","volume":"17","author":"Chen","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1039\/D2TB00614F","article-title":"Latest on biomaterial-based therapies for topical treatment of psoriasis","volume":"10","author":"Chen","year":"2022","journal-title":"J Materials Chem B"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2205847","DOI":"10.1002\/adfm.202205847","article-title":"Biologics-loaded photothermally dissolvable hyaluronic acid microneedle patch for psoriasis treatment","volume":"32","author":"Wu","year":"2022","journal-title":"Advanced Funct Materials"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2022.10.025","article-title":"Design principles of microneedles for drug delivery and sampling applications","author":"Le","year":"2022","journal-title":"Materials Today"},{"key":"B93","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1021\/acsnano.0c10724","article-title":"Emerging functional biomaterials as medical patches","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.900274","article-title":"A modified hyaluronic acid\u2013based dissolving microneedle loaded with daphnetin improved the treatment of psoriasis","author":"Peng","year":"2022","journal-title":"Front Bioengineering Biotechnol 10"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.9b15668","article-title":"Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis","volume":"11","author":"Du","year":"2019","journal-title":"ACS Appl Materials Interfaces"},{"key":"B96","doi-asserted-by":"publisher","first-page":"122207","DOI":"10.1016\/j.ijpharm.2022.122207","article-title":"Tacrolimus nanocrystals microneedle patch for plaque psoriasis","volume":"627","author":"Men","year":"2022","journal-title":"Int J Pharmaceutics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1089262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:01:01Z","timestamp":1671710461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1089262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2022.1089262"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1089262","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1089262"}}